Conjunctivitis pathophysiology

Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]

Conjunctivitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Conjunctivitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Case Studies

Case #1

Conjunctivitis pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Conjunctivitis pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Conjunctivitis pathophysiology

CDC on Conjunctivitis pathophysiology

Conjunctivitis pathophysiology in the news

Blogs on Conjunctivitis pathophysiology

Directions to Hospitals Treating Conjunctivitis

Risk calculators and risk factors for Conjunctivitis pathophysiology

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Pathophysiology

Infective Conjunctivitis is spread from:

  • Direct contact with the infected person’s eye drainage or drainage from the person’s cough, sneeze, or runny nose
  • Contact with the infected person’s fingers, hands or objects that may have the infected person’s drainage on them (e.g. eye makeup applicators, towels, shared eye medications)
  • Adjacent infectious sites (rubbing of the eyes)

Any change in the host defense or in the species of normal flora of the eye (such as streptococci, staphylococci, and corynebacteria) can lead to clinical infection and Conjunctivitis.[1] Change in the flora can occur by:


Newborns can be infected by bacteria in the birth canal. This condition is called ophthalmia neonatorum, and it must be treated immediately to preserve eyesight.  Additionally, neonatal conjunctivitis is a red eye in a newborn caused by irritation, a blocked tear duct, or infection.

Development of Allergic Conjunctivitis is result of type I hypersensitivity reactions involving the conjunctiva. [2]

  • IgE-mediated immediate hypersensitivity reaction and Mast cell play an important role in these allergic inflammations

In Giant papillary conjunctivitis combination of type I and type IV hypersensitivity reactions may be responsible. Also prolonged mechanical irritation to the superior tarsal conjunctiva, of the upper lid, from any of a variety of foreign bodies may also be a contributing factor in Giant papillary conjunctivitis.[3][4] Airborne antigens may be involved in the pathogenesis of Allergic Conjunctivitis. Common airborne antigens, include:[5][6]

There is a strong association with atopic dermatitis and Allergic Conjunctivitis.

Gross Pathology

Viral Conjunctivitis[7]









Microscopic Pathology

Chlamydial conjunctivitis (Day 5-14)[8]












References

  1. Everitt H, Kumar S, Little P (2003). "A qualitative study of patients' perceptions of acute infective conjunctivitis". Br J Gen Pract. 53 (486): 36–41. PMC 1314490. PMID 12564275.
  2. Kyei S, Koffuor GA, Ramkissoon P, Abokyi S, Owusu-Afriyie O, Wiredu EA (2015). "Possible Mechanism of Action of the Antiallergic Effect of an Aqueous Extract of Heliotropium indicum L. in Ovalbumin-Induced Allergic Conjunctivitis". J Allergy (Cairo). 2015: 245370. doi:10.1155/2015/245370. PMC 4657065. PMID 26681960.
  3. Donshik PC (1994). "Giant papillary conjunctivitis". Trans Am Ophthalmol Soc. 92: 687–744. PMC 1298525. PMID 7886881.
  4. Donshik PC, Porazinski AD (1999). "Giant papillary conjunctivitis in frequent-replacement contact lens wearers: a retrospective study". Trans Am Ophthalmol Soc. 97: 205–16, discussion 216-20. PMC 1298261. PMID 10703125.
  5. Malling HJ, Montagut A, Melac M, Patriarca G, Panzner P, Seberova E; et al. (2009). "Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis". Clin Exp Allergy. 39 (3): 387–93. doi:10.1111/j.1365-2222.2008.03152.x. PMC 4233960. PMID 19134019.
  6. Kämpe M, Stålenheim G, Janson C, Stolt I, Carlson M (2007). "Systemic and local eosinophil inflammation during the birch pollen season in allergic patients with predominant rhinitis or asthma". Clin Mol Allergy. 5: 4. doi:10.1186/1476-7961-5-4. PMC 2174506. PMID 17967188.
  7. Image Courtesy of Joyhil09 [1]
  8. http://picasaweb.google.com/mcmumbi/USMLEIIImages


Template:WikiDoc Sources